In France, the conduct of clinical trials requires a prior express favourable opinion of a Committee for the protection of the persons, in French Comité de protection des personnes (CPP). The competent CPPs have been designated randomly, by means of a draw since a law of 2012, implemented in November 2016. However, the random designation did […]
About Virginie Langlois
This author has yet to write their bio.Meanwhile lets just say that we are proud Virginie Langlois contributed a whooping 4 entries.
Entries by Virginie Langlois
Registration for the 2019 conference of the European Federation for Exploratory Medicines Development (EUFEMED) is now open! The event will be held from May 15 – 17, 2019 in Lyon, France. The conference once again has an exciting scientific programme: The Changing Landscape of Early Medicines Development: Be Prepared! The two-day meeting will include a mixture of […]
On 19 September, EUFEMED organized a successful Forum discussion at the University of Leuven in Belgium. The audience was invited to directly interact with the panel of regulators, leading to fruitful discussions to identify and mitigate risks for first-in-human and early clinical trials. Thanks to the speakers for contributing to the great success of this […]
For the 30th annual meeting of GMP, the AFPT president, Henri Caplain, MD, MSc gave an interesting and informative presentation focussed on the question “Transporter-medicated DDIs, are they clinically relevant?” Download the presentation below: Slides_Henri Caplain_Transporter-mediated drug interaction
Association des professionnels
du développement précoce des medicaments
A founding member of
The next workshop of the Association for Applied Human Pharmacology (AGAH) will be held on January 24 & 25, 2019 in Bonn, Germany. Participants
The next workshop of the Association for Applied Human Pharmacology (AGAH) will be held on January 24 & 25, 2019 in Bonn, Germany.
Participants of this two-day workshop will learn about the implementation of translational approaches to support dose selection and dose escalation schemes in early clinical trials.
january 24 (Thursday) - 25 (Friday)